Mon. Dec 5th, 2022

 

Note: The following article is educational and does not represent any form of medical advice. Please take medical decisions only after receiving advice from accredited physicians.

Since we were young, we have been given information, either directly or indirectly, and we took them as facts because this is how we also saw the patterns connecting. In other words, we connected the stars that were shown to us and we discovered a constellation. What if I told you that there is a greater constellation than the one shown to us, and that greater constellation might just change our perception of reality? Well, not completely, since all degrees of matter exist regardless. This is about determining the real shape of things. And the theme of this post is part of medical science and how it has been manipulated through politically and financially-motivated scientists and doctors, and how the mainstream media has been used as an informational weapon to keep us distracted.

Everything given to us that was not nature friendly has been presented as healthy and the sole solutions to preserve our species. From molecular cloning and the development of GMO crops, to conserving foods and drinks using compounds with controversial ingredients, to the promotion of scientific and ideological currents, such as Malthusianism and Cornucopianism, in which we are told how humanity will be doomed due to overpopulation and that the only solution is to use molecular cloning, genetic manipulation and preservatives with controversial ingredients as a way to have enough resources in the future. The truth is that overpopulation is real because entire populations had been moved into big cities due to planned past and future industrial revolutions. Nature has been harmed in an unprecedented manner, and the establishment is mainly guilty, and not the civilians, although I believe everybody is equally responsible with preserving nature. Furthermore, “Human Augmentation” is another promoted current by worldwide executive powers, and the intent behind it is apparently to change the laws of evolution by natural selection to evolution by intelligent design; in other words, for the establishment to play God over humanity. I would like to remind these individuals that human augmentation is in clear violation to Mother Nature and such an action will bring a rapid process of natural de-selection. Already, the chaotic mass COVID-19 vaccination campaigns and the promotion of two boosters is bringing this natural de-selection by means of a mass immunological suppression.

Figure 1: The human brain has the sharpest development rate in the first two years of life (The Urban Child Institute, 2011)

Scientists may still be in the introductory stages of research, and there might be a significant and profound degree of association between the immune system and a healthy neurological development, which means that pathogenic immune evasion may also represent an important factor of the onset of fetal neurodevelopmental delays. Virtually all immune cells and numerous immune pathways have associations with neuronal production, growth (neurogenesis) and maintenance, and innovative research broadly used this fact to explore the efficacy rates of various drugs to treat immunological and oncological diseases. Anti-inflammatory chemokines and cytokines generally play a role in neuroprotection, whilst pro-inflammatory chemokines and cytokines, as well as antibody activation and the recruitment of the vast majority of immune cells, have a bi-directional influence upon neurogenesis rates; a restricted extent of immune activation stimulates neurogenesis whilst exaggerated immune responses inhibit it. Ultimately, it is both exaggerated neurogenesis and inhibited neurogenesis that may affect healthy rates of neurodevelopment in fetuses and babies, given their critical stages of neurological development. And immune-related neurodevelopmental disease (autism) is rather induced by a long sequence of numerous faster and slower rates of neurogenesis. A further apprehension of the relationship between developmental immunity and neurology is essential for innovative research in both immunology and neurology, and it may even be that some major areas of traditional vaccinology may be implicated in this association that requires further scientific analysis.

With regards to vaccination, I would like to make some aspects clear; I am not anti-vax at all. Throughout my life, I had many vaccines administered to me, and I have only not received the flu, the HPV and the COVID-19 ones. MMR vaccines alone are quite likely not significantly associated with a higher incidence of autism, and using a few live-attenuated pathogens to immunise young children aged 0-2 might actually stimulate a healthy development of the brain. Nevertheless, the MMR vaccine involves the injection of three different kinds of antigens, which train the immune system to fight against three different kinds of pathogenic agents simultaneously, and this could cause a pronounced development of a few neuronal regions and, consequently, discrepancies in the developmental rates of diverse important neuronal networks due to the clear association between the development of the adaptive immune system and the development of the central nervous system. The injection of dozens of vaccines in children from this age group is associated with a greater incidence of autism, as there is a solid bridge between the adaptive immune system and the brain, and the development of the adaptive immune system influences the development of important brain sub-regions. The brain has the most pronounced development until the age of 2, and it has been scientifically proven that the infection of the mother with certain pathogens during pregnancy is associated with a higher probability of the baby to develop autism after birth. This is because the immune system of the faetus is dependent upon the immune system of the mother, and once the mother is infected, automatically the faetus is infected too and will develop antibodies against the pathogen. However, that will bring a higher pressure upon certain brain sub-regions to develop because of the link between the adaptive immune system and the brain. This higher pressure will cause some brain sub-regions to over-develop, and others to under-develop, and this discrepancy will more possibly result in a neurodevelopment delay, which is also known as autism spectrum disease. It is more probable that such a repeated vaccination of the baby will lead to the onset of neurodevelopmental delays if the mother had suffered from a significant infectious disease during pregnancy, since the fetus had been exposed to the pathogen as well at that time, and that led to the activation of the immune system of the fetus and an increased demand for neurological developments due to the bridge between the development of the adaptive immune system and neurological development.

Figure 2: The developmental rate of three important sub-sections of the brain during the first stages of postnatal life (Lutein, Brain and Neurological Functions, 2015)

It is possible that the infection of babies any time within their first few years of life could also considerably increase the risk of the onset of neurodevelopmental disease, and this may include a sharper increase of adaptive immune memory without the development of physical disease. It is important to note that the highest developmental rate of the higher cognitive function takes place at around one year of age, whilst the highest developmental rate of language takes place at around eight months of age. And, if maternal infection during pregnancy already constitutes a risk factor for neurodevelopmental disease in offspring, then it could be more likely that the intake of pathogens and antigens by the host cells of babies aged 0-2 leads to the onset of diverse forms of neurodevelopmental disease. However, the intake of more numerous kinds of pathogens and antigens within the first two years of life could be associated with a more significant risk of the onset of neurodevelopmental delays, just as there is a significant higher risk for the onset of neurodevelopmental delays in foetuses whose mothers experienced more significant infectious diseases. A normal process of immunisation really does not seem to constitute the actual problem, but a much sharper process of immunisation over the first stages of life in case of an exposure to one dangerous pathogen or more numerous kinds of pathogens and antigens that normally cause moderate disease morbidity. A normal process of immunisation in foetuses and infants actually stimulates a healthy and balanced development of all brain regions. The more dangerous the pathogenic agent and its antigens are, the sharper the development of the adaptive immune memory will be, and the same happens in the case of an increased number of infectious pathogens and antigens that have infected the cells of the mothers and the foetuses in cause, and this may, in the majority of the situations, still be the case even if the pathogens are already significantly weakened or lifeless, given that the gain of adaptive immune memory alone constitutes an important factor of neurogenesis and an increased rate of neurological development, and that the infant will become almost or fully protected against the pathogens in cause, despite not having experienced the disease beforehand. And in this case, neurodevelopmental delays are not caused by an impaired neurogenesis, but by an excessive one. It is important to mention that a dose of infant immunisation does bring significantly lower risks of adverse neurological events than the onset of a significant maternal infectious disease during pregnancy. Likewise, this seems to be more like a matter of quantity and repetition, whose necessity looks valid, given the far less mature stages of infant immunity.

At this point, we can see there is a possibility that one or a few sessions of interferon-based and interferon-oriented immunisation could be safer for babies aged 0-2 than the administration of dozens of pathogen-based vaccines, some of which stimulate the adaptive immune system to simultaneously develop responses and memory against multiple pathogens. Could it really be that such interferon-based and interferon-oriented vaccines, which sharpen the innate immune system and shape qualitative adaptive immune responses if used within the right early timing, are the vaccines of the future? Maybe we are also approaching a stage of medical progress in which we no longer require the usage of needles either.

 

Figure 3: A significant link between the adaptive immune system and brain development shows there is a need for caution, just as there is a need for caution in all aspects of medicine (source: https://www.frontiersin.org/files/Articles/468190/fnins-13-00916-HTML-r1/image_m/fnins-13-00916-g001.jpg)

We know that there is no difference between infection and vaccination when it comes to the extent of the gained memory of the adaptive immune system. Likewise, when it comes to the developmental rate of the adaptive immune system and the brain, there is no difference between giving babies dozens of vaccines and infecting them with dozens of pathogens. Imagine if the faetus can have smaller or greater implications upon their overall brain developmental rate if the mother is infected during pregnancy, then we can rest assured that giving babies many vaccines will raise their probability to develop smaller or greater issues with regards to the overall brain development. The truth is always in the middle, and the mainstream media and scientists have done a marvellous job at suppressing the truth by focusing on the other extreme to combat an extreme.

Dr. Louis Pasteur himself could be rolling in the grave, seeing these numerous mass vaccination campaigns for newborns and babies, which are rather aggressive and a little bizarre.

Figure 4: A manifesto that questions the efficacy of giving newborns and babies a higher number of vaccines based on live-attenuated pathogens. The most recent statistics show that around 1 in 44 people in the USA were diagnosed with autism in 2021.

Sadly, it is possible that, by 2050, up to a half of the world’s population will be diagnosed with autism, given the trend created with the data above. The problem is that the establishment has done an excellent job at normalizing disease and manipulating public opinion into believing that it is impossible that unnatural causes of disease started to infiltrate and in some areas even dominate during the recent sharp improvement of the tools to detect disease.

If we combine this potential issue with the fact that countless children and teenagers are habitually consuming junk-food, using technology excessively and relying on automation whilst performing important daily tasks, then I believe we should be really worried when it comes to the extension of the neurodevelopmental issue among world populations, especially in countries that are meant to be developed. A regular consumption of GMOs could also play a role in increasing the incidence of neurodevelopmental issues for the next generations. Autism is also referred to as a form of brain inflammation or a partial mental blindness due to the generally narrow focus of many people on the spectrum. Perhaps, the fact that autism can be deemed as a form of partial mental blindness explains why people on the autistic spectrum tend to experience more episodes of depersonalisation, especially while feeling overwhelmed. Furthermore, there is a strong link between neurodevelopmental disease, amplification and hormonal dysregulation. For example, the natural female-to-male occasional dominance (i.e. during intimacy) is often amplified in individuals with diverse forms of neurodevelopmental delays, and this amplification involved an induced hormonal dysregulation, which is often mild, but sometimes gets more serious. Reverse roles of male to female relationships have reached levels of mainstream acceptance and this is no coincidence. A mass neurodevelopmental delay is at least an important factor of this, which in turn is caused by multiple factors, such as abuse of technology that has affected people of all age groups and health conditions, mass relocations to areas that are separated from nature, poor diet and the normalisation of eating junk food, intoxication of the air in big cities, automation of work tasks, programmed 2D thinking and emotions via television, social media, the educational system and the employment system, and the administration of numerous vaccines to newborns and babies, when critical stages of brain development take place at that time. Sadly, if this continues, we will witness an exponential growth of the number of people who develop mentally and even systemically crippling diseases, as given that autism is a disease of the central nervous system (developmental delays of important encephalon components) and that the nervous system co-ordinates all bodily functions, an exponential growth in the number of people diagnosed with autism will result in an exponential growth in the number of people diagnosed with countless diseases, ultimately in any important area of their body, in the next generations. Many people in the future could sadly develop diseases and not be able to find the causes at all and, in the end, there could be an incredibly high number of people spending most of their life in hospital, all around the world. This post is about a general call to awakening of our consciousness, as this is the only way to find the truth about how the world really works.

It is important to note that this post is not about pointing fingers to any kind of groups and backgrounds, and nor is it encouraging people to hate on doctors and nurses, but it is only a discussion based on biology. I would like to make something clear; autism is not entirely a disease, and people on the spectrum are not handicapped or any lesser of a human. On the contrary, people on the spectrum are generally more gifted than average and the majority of the geniuses and experts who changed the world were on the spectrum, more or less. I personally believe that autism will set mankind free and, if it was used as a weapon by the elites, then this weapon will turn against them. This is because most people on the spectrum become high functioning; they generally have stronger and more precise moral objectives and ultimately become more adapted to the environment than people who are not on the spectrum. Likewise, do not worry because nature will have her revenge, sooner or later.

The projected trend includes long-term increases in promiscuity and also pedophilia

I would like to expose the following; a more widespread neurodevelopmental issue caused by all the factors mentioned above are including something sinister; impact upon the development of romantic and physical attractions, besides already causing a significant loss of regulation of physical intimacy between partners, which is leading to the normalisation of inappropriate behaviours in public and eventually to a pronouncedly increased level of promiscuity in society. The West had already experienced a severe increase in the number of divorces due to significant levels of accepted promiscuity and toxic ideologies, which have been normalising a “hook-up” culture, especially among young people. Dr. Jordan Peterson, a world-renowned clinical psychologist, has given irrefutable evidence that the “hook-up” culture has been destroying the family unit and the individuals making the family unit alike, and this “hook-up” culture represents an important contributor to the problem of abortion of embryos and foetuses where the woman could have said no (there are more than 63 million aborted embryos and foetuses in the United States of America alone), and not to mention that this twisted “culture” also increased the incidences of rape, which in turn also contributed to the rise of the number of unwanted pregnancies. The scientific communities around Harvard University actually came to the conclusion that life begins at conception, and not even when the first heartbeat occurs. Moreover, autistic individuals tend to have increased levels of produced and secreted androgenic hormones, and excessive levels of such hormones are associated with behaviours that are more animalistic in nature, which automatically means the “lizard” area of the brain is more active and can be more stimulated than normal, ultimately resulting in a significant loss of thought and behavioural control in many cases. Not all people that develop autism either genetically or epigenetically are prepared to handle the gifts of autism and many will not realise that their animalistic instincts are higher. As a result, as multiple generations will pass, eventually it will be many who will not have a significant control over their own behaviour, as chemical messengers, like hormones, will be produced more abundantly than normal. There could be a hyper-natural selection of people in the future, which could implicate a general societal chaos before morally, psychologically and emotionally strong people will bring societal conditions that could seem even better at first than the ones before this induced hyper-“natural” selection process, before the end of the life of humanity on Earth. The purpose of this artificially-induced hyper-selection is to make the selected few people like the powerful (meaning that, just as the state of the powerful reflects the state of society, so will the state of society reflect the state of the powerful). The process of true natural selection cannot be artificially influenced and likewise, the powerful have already started playing Mother Nature in dangerous ways. In other words, there may have been a plan for a forced human evolution to the point of the creation and selection of a super-human species, and in such a process, the majority of people would become naturally de-selected (cause chaos and  die), and very few would survive and become “super-humans”. The most important cause of this process would be the mass exposure to such autization factors during key stages of neuro-immunological development. This would not just be a next-level dystopic scenario, but would also perfectly play into the depopulation agenda.

Neurodevelopmental delays are often so serious that they affect areas of personality and identity, which means that potentially induced neurodevelopmental delays may cause brain sub-regions involved in attractions to have a delayed growth more often than we may think, and likewise, the problem could unfortunately include a significant increase the incidences of pedophilia long-term. An important sign that this is the case is that leuprolide acetate with tibolone, pregnenolone and even potassium chloride are therapeutic agents that help both people on the autistic spectrum and people with pedophilic tendencies. A deficiency of pregnenolone is caused by a deficiency of neurosteroids, and this deficiency is significantly associated with a reduced conversion of cholesterol to pregnenolone in the mitochondria of oligodendrocytes, which are cells in the brain. Neurosteroid deficiency is also associated with a higher incidence of autism and epilepsy (Vitamin D3 represents an important example of neurosteroids). Moreover, the topiramate anticonvulsant agent showed efficacy against autism and, in combination with carbamazepine, against pedophilia too. Somebody needs to mention these aspects so all the major problems will be exposed.

 

Given that gonadotropin-releasing hormone agonists (GnRHs) are produced by the hypothalamus (a region of the brain) and that exogenous GnRHs (for instance, leuprolide acetate) decrease symptoms of both pedophilia and serious forms of neurodevelopmental disorders, and that potassium chloride also treats both conditions, there are definitely reasons to believe there is a link between a higher incidence of serious forms of neurodevelopmental disorders and an increase of detected cases of pedophilia.

Because of the risks of significant neurodevelopmental delays on the integrity of neurological networks responsible with romantic and physical attraction, as well as personality, autism could actually become the disease of the 21st century, given that these unprecedented changes of lifestyle in the world are inducing unprecedented problems with regards to overall brain development. Teens are attracted to fellow teens. Adults are attracted to fellow adults. In serious cases of neurodevelopmental disease, however, the previous teen attraction can often fail to switch to an adult attraction, although physically, the person becomes an adult. This is because of a neurodevelopmetal delay in the areas of the brain responsible with that. For example, because there are delays in the development of the hypothalamus, there is a lower amount of produced GnRHs, which is associated with abnormal attractions. Of course, this is not to say that the majority of people on the spectrum also have abnormal romantic and physical attractions, but rather that an exponential increase of diagnosed cases of autism will very sadly come hand in hand with an exponential increase of diagnosed cases of pedophilia.

This figure shows the high importance of the normal rate of pregnenolone synthesis to preserve mental health and stimulate healthy social behaviours and attraction. A higher rate of neurosteroid activity is associated with a higher ability of neurogenesis and neuroregeneration following brain injury. Serious neurodevelopmental issues are often associated with a deficiency of pregnenolone (source of the figure: https://www.researchgate.net/publication/321349636_Neurosteroids_and_Ischemic_Stroke_Progesterone_a_Promising_Agent_in_Reducing_the_Brain_Injury_in_Ischemic_Stroke).

The good news is that these problems can be resolved using innovative methods of therapy and building of partially-developed neurological networks. Applications of Nikola Tesla’s principles into electricity-based therapy, high frequency-based therapies using a number of models presented by Dr. Rife and Transcranial Magnetic Stimulation (TMS) seem to be excellent starting candidates. Of course, then come other important approaches, such as Ultraviolet B radiation-based therapies, the administration of injectable compounds and supplements, such as cerebrolysin, and the addition of Prevotella bivia bacteria into the gut microbiota of the affected people. This is really a matter of connecting the dots of the small details to create the actual big picture. I recently invented a saying; “If God wants us to become like Him, then rest assured that the devil also wants us to become like him”. Overall, such consecutive negative changes take place gradually and in a subtle way, which causes the general public not to notice. But in the end, they will lead to a complete chaos around the world, and I believe we are closer to that chaos than many of us think. If some of you think I am exaggerating, then please accept my sincere apologies. But I personally believe we should be safe, rather than sorry.

 

Bibliography:

 

  1. Pollard, A.J., Bijker, E.M. A guide to vaccinology: from basic principles to new developments. Nat Rev Immunol 21, 83–100 (2021). https://doi.org/10.1038/s41577-020-00479-7
  2. Yang, J., Qi, F., Gu, H., Zou, J., Yang, Y., Yuan, Q., & Yao, Z. (2016). Neonatal BCG vaccination of mice improves neurogenesis and behavior in early life. Brain research bulletin120, 25–33. https://doi.org/10.1016/j.brainresbull.2015.10.012
  3. Morimoto K and Nakajima K (2019) Role of the Immune System in the Development of the Central Nervous System. Front. Neurosci. 13:916. doi: 10.3389/fnins.2019.00916
  4. Baines KJ, Hillier DM, Haddad FL, Rajakumar N, Schmid S and Renaud SJ (2020) Maternal Immune Activation Alters Fetal Brain Development and Enhances Proliferation of Neural Precursor Cells in Rats. Front. Immunol. 11:1145. doi: 10.3389/fimmu.2020.01145
  5. Denes A and Miyan JA (2014) Brain-immune interactions in health and disease. Front. Neurosci8:382. doi: 10.3389/fnins.2014.00382
  6. Kamimura D, Yamada M, Harada M, Sabharwal L, Meng J, Bando H, Ogura H, Atsumi T, Arima Y and Murakami M (2013) The gateway theory: bridging neural and immune interactions in the CNS. Front. Neurosci7:204. doi: 10.3389/fnins.2013.00204
  7. Geenen V, Bodart G, Henry S, Michaux H, Dardenne O, Charlet-Renard C, Martens H and Hober D (2013) Programming of neuroendocrine self in the thymus and its defect in the development of neuroendocrine autoimmunity. Front. Neurosci7:187. doi: 10.3389/fnins.2013.00187
  8. Goyal DK and Miyan JA (2014) Neuro-immune abnormalities in autism and their relationship with the environment: a variable insult model for autism. Front. Endocrinol. 5:29. doi: 10.3389/fendo.2014.00029
  9. Lutein, Brain, and Neurological Functions. (2015). Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease, 41–47. https://doi.org/10.1016/b978-0-12-411462-3.00004-7
  10. Qi, F., Zuo, Z., Yang, J., Hu, S., Yang, Y., Yuan, Q., Zou, J., Guo, K., & Yao, Z. (2017). Combined effect of BCG vaccination and enriched environment promote neurogenesis and spatial cognition via a shift in meningeal macrophage M2 polarization. Journal of neuroinflammation14(1), 32. https://doi.org/10.1186/s12974-017-0808-7
  11. Qi, F., Zuo, Z., Hu, S., Xia, Y., Song, D., Kong, J., Yang, Y., Wu, Y., Wang, X., Yang, J., Hu, D., Yuan, Q., Zou, J., Guo, K., Xu, J., & Yao, Z. (2018). An enriched environment restores hepatitis B vaccination-mediated impairments in synaptic function through IFN-γ/Arginase1 signaling. Brain, behavior, and immunity71, 116–132. https://doi.org/10.1016/j.bbi.2018.04.003
  12. Yang, J., Qi, F., Yang, Y., Yuan, Q., Zou, J., Guo, K., & Yao, Z. (2016). Neonatal hepatitis B vaccination impaired the behavior and neurogenesis of mice transiently in early adulthood. Psychoneuroendocrinology73, 166–176. https://doi.org/10.1016/j.psyneuen.2016.08.002
  13. Wang, X., Yang, J., Xing, Z., Zhang, H., Wen, Y., Qi, F., Zuo, Z., Xu, J., & Yao, Z. (2018). IL-4 mediates the delayed neurobehavioral impairments induced by neonatal hepatitis B vaccination that involves the down-regulation of the IL-4 receptor in the hippocampus. Cytokine110, 137–149. https://doi.org/10.1016/j.cyto.2018.04.037
  14. Qi, F., Yang, J., Xia, Y., Yuan, Q., Guo, K., Zou, J., & Yao, Z. (2016). A(H1N1) vaccination recruits T lymphocytes to the choroid plexus for the promotion of hippocampal neurogenesis and working memory in pregnant mice. Brain, behavior, and immunity53, 72–83.
  15. Xia, Y., Qi, F., Zou, J., Yang, J., & Yao, Z. (2014). Influenza vaccination during early pregnancy contributes to neurogenesis and behavioral function in offspring. Brain, behavior, and immunity42, 212–221. https://doi.org/10.1016/j.bbi.2014.06.202
  16. Han, V. X., Patel, S., Jones, H. F., Nielsen, T. C., Mohammad, S. S., Hofer, M. J., Gold, W., Brilot, F., Lain, S. J., Nassar, N., & Dale, R. C. (2021). Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: a systematic review. Translational psychiatry11(1), 71. https://doi.org/10.1038/s41398-021-01198-w
  17. Zhang, Z., & van Praag, H. (2015). Maternal immune activation differentially impacts mature and adult-born hippocampal neurons in male mice. Brain, behavior, and immunity45, 60–70. https://doi.org/10.1016/j.bbi.2014.10.010
  18. Meyer, U., Nyffeler, M., Yee, B. K., Knuesel, I., & Feldon, J. (2008). Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain, behavior, and immunity22(4), 469–486. https://doi.org/10.1016/j.bbi.2007.09.012
  19. Han, V. X., Patel, S., Jones, H. F., & Dale, R. C. (2021). Maternal immune activation and neuroinflammation in human neurodevelopmental disorders. Nature reviews. Neurology, 17(9), 564–579. https://doi.org/10.1038/s41582-021-00530-8
  20. Han, V. X., Patel, S., Jones, H. F., Nielsen, T. C., Mohammad, S. S., Hofer, M. J., Gold, W., Brilot, F., Lain, S. J., Nassar, N., & Dale, R. C. (2021). Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: a systematic review. Translational psychiatry, 11(1), 71. https://doi.org/10.1038/s41398-021-01198-w
  21. Lombardo, M. V., Moon, H. M., Su, J., Palmer, T. D., Courchesne, E., & Pramparo, T. (2018). Maternal immune activation dysregulation of the fetal brain transcriptome and relevance to the pathophysiology of autism spectrum disorder. Molecular psychiatry23(4), 1001–1013. https://doi.org/10.1038/mp.2017.15
  22. Haddad, F. L., Patel, S. V., & Schmid, S. (2020). Maternal Immune Activation by Poly I:C as a preclinical Model for Neurodevelopmental Disorders: A focus on Autism and Schizophrenia. Neuroscience and biobehavioral reviews113, 546–567. https://doi.org/10.1016/j.neubiorev.2020.04.012
  23. Trifonova, E. A., Mustafin, Z. S., Lashin, S. A., & Kochetov, A. V. (2022). Abnormal mTOR Activity in Pediatric Autoimmune Neuropsychiatric and MIA-Associated Autism Spectrum Disorders. International journal of molecular sciences23(2), 967. https://doi.org/10.3390/ijms23020967
  24. Han, V. X., Patel, S., Jones, H. F., Nielsen, T. C., Mohammad, S. S., Hofer, M. J., Gold, W., Brilot, F., Lain, S. J., Nassar, N., & Dale, R. C. (2021). Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: a systematic review. Translational psychiatry11(1), 71. https://doi.org/10.1038/s41398-021-01198-w
  25. Meltzer, A., & Van de Water, J. (2017). The Role of the Immune System in Autism Spectrum Disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology42(1), 284–298. https://doi.org/10.1038/npp.2016.158
  26. Beversdorf, D. Q., Stevens, H. E., & Jones, K. L. (2018). Prenatal Stress, Maternal Immune Dysregulation, and Their Association With Autism Spectrum Disorders. Current psychiatry reports20(9), 76. https://doi.org/10.1007/s11920-018-0945-4
  27. McLellan, J., Kim, D., Bruce, M., Ramirez-Celis, A., & Van de Water, J. (2022). Maternal Immune Dysregulation and Autism-Understanding the Role of Cytokines, Chemokines and Autoantibodies. Frontiers in psychiatry13, 834910. https://doi.org/10.3389/fpsyt.2022.834910
  28. Jones, K. L., & Van de Water, J. (2019). Maternal autoantibody related autism: mechanisms and pathways. Molecular psychiatry24(2), 252–265. https://doi.org/10.1038/s41380-018-0099-0
  29. Beversdorf, D. Q., Shah, A., Jhin, A., Noel-MacDonnell, J., Hecht, P., Ferguson, B. J., Bruce, D., Tilley, M., & Talebizadeh, Z. (2021). microRNAs and Gene-Environment Interactions in Autism: Effects of Prenatal Maternal Stress and the SERT Gene on Maternal microRNA Expression. Frontiers in psychiatry12, 668577. https://doi.org/10.3389/fpsyt.2021.668577
  30. Boktor, J. C., Adame, M. D., Rose, D. R., Schumann, C. M., Murray, K. D., Bauman, M. D., Careaga, M., Mazmanian, S. K., Ashwood, P., & Needham, B. D. (2022). Global metabolic profiles in a non-human primate model of maternal immune activation: implications for neurodevelopmental disorders. Molecular psychiatry, 10.1038/s41380-022-01752-y. Advance online publication. https://doi.org/10.1038/s41380-022-01752-y
  31. Abdallah, M. W., Larsen, N., Grove, J., Nørgaard-Pedersen, B., Thorsen, P., Mortensen, E. L., & Hougaard, D. M. (2013). Amniotic fluid inflammatory cytokines: potential markers of immunologic dysfunction in autism spectrum disorders. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry14(7), 528–538. https://doi.org/10.3109/15622975.2011.639803
  32. Abdallah, M. W., Larsen, N., Mortensen, E. L., Atladóttir, H. Ó., Nørgaard-Pedersen, B., Bonefeld-Jørgensen, E. C., Grove, J., & Hougaard, D. M. (2012). Neonatal levels of cytokines and risk of autism spectrum disorders: an exploratory register-based historic birth cohort study utilizing the Danish Newborn Screening Biobank. Journal of neuroimmunology252(1-2), 75–82. https://doi.org/10.1016/j.jneuroim.2012.07.013
  33. Abdallah, M. W., Larsen, N., Grove, J., Bonefeld-Jørgensen, E. C., Nørgaard-Pedersen, B., Hougaard, D. M., & Mortensen, E. L. (2013). Neonatal chemokine levels and risk of autism spectrum disorders: findings from a Danish historic birth cohort follow-up study. Cytokine61(2), 370–376. https://doi.org/10.1016/j.cyto.2012.11.015
  34. Abdallah, M. W., Pearce, B. D., Larsen, N., Greaves-Lord, K., Nørgaard-Pedersen, B., Hougaard, D. M., Mortensen, E. L., & Grove, J. (2012). Amniotic fluid MMP-9 and neurotrophins in autism spectrum disorders: an exploratory study. Autism research : official journal of the International Society for Autism Research5(6), 428–433. https://doi.org/10.1002/aur.1254
  35. Missault, S., Van den Eynde, K., Vanden Berghe, W., Fransen, E., Weeren, A., Timmermans, J. P., Kumar-Singh, S., & Dedeurwaerdere, S. (2014). The risk for behavioural deficits is determined by the maternal immune response to prenatal immune challenge in a neurodevelopmental model. Brain, behavior, and immunity42, 138–146. https://doi.org/10.1016/j.bbi.2014.06.013
  36. Han, V. X., Jones, H. F., Patel, S., Mohammad, S. S., Hofer, M. J., Alshammery, S., Maple-Brown, E., Gold, W., Brilot, F., & Dale, R. C. (2022). Emerging evidence of Toll-like receptors as a putative pathway linking maternal inflammation and neurodevelopmental disorders in human offspring: A systematic review. Brain, behavior, and immunity, 99, 91–105. https://doi.org/10.1016/j.bbi.2021.09.009
  37. Chen, S., Zhao, S., Dalman, C., Karlsson, H., & Gardner, R. (2021). Association of maternal diabetes with neurodevelopmental disorders: autism spectrum disorders, attention-deficit/hyperactivity disorder and intellectual disability. International journal of epidemiology, 50(2), 459–474. https://doi.org/10.1093/ije/dyaa212
  38. Wiegersma, A. M., Dalman, C., Lee, B. K., Karlsson, H., & Gardner, R. M. (2019). Association of Prenatal Maternal Anemia With Neurodevelopmental Disorders. JAMA psychiatry, 76(12), 1294–1304. https://doi.org/10.1001/jamapsychiatry.2019.2309
  39. Wang, Z., Chan, A., Coghill, D., Ip, P., Lau, W., Simonoff, E., Brauer, R., Wei, L., Wong, I., & Man, K. (2021). Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age. JAMA internal medicine, 181(10), 1332–1340. https://doi.org/10.1001/jamainternmed.2021.4571
  40. Brand, J. S., Lawlor, D. A., Larsson, H., & Montgomery, S. (2021). Association Between Hypertensive Disorders of Pregnancy and Neurodevelopmental Outcomes Among Offspring. JAMA pediatrics, 175(6), 577–585. https://doi.org/10.1001/jamapediatrics.2020.6856
  41. Bergdolt, L., & Dunaevsky, A. (2019). Brain changes in a maternal immune activation model of neurodevelopmental brain disorders. Progress in neurobiology, 175, 1–19. https://doi.org/10.1016/j.pneurobio.2018.12.002
  42. Ryan, A. M., & Bauman, M. D. (2022). Primate Models as a Translational Tool for Understanding Prenatal Origins of Neurodevelopmental Disorders Associated With Maternal Infection. Biological psychiatry. Cognitive neuroscience and neuroimaging, 7(5), 510–523. https://doi.org/10.1016/j.bpsc.2022.02.012
  43. Vlasova, R. M., Iosif, A. M., Ryan, A. M., Funk, L. H., Murai, T., Chen, S., Lesh, T. A., Rowland, D. J., Bennett, J., Hogrefe, C. E., Maddock, R. J., Gandal, M. J., Geschwind, D. H., Schumann, C. M., Van de Water, J., McAllister, A. K., Carter, C. S., Styner, M. A., Amaral, D. G., & Bauman, M. D. (2021). Maternal Immune Activation during Pregnancy Alters Postnatal Brain Growth and Cognitive Development in Nonhuman Primate Offspring. The Journal of neuroscience : the official journal of the Society for Neuroscience, 41(48), 9971–9987. https://doi.org/10.1523/JNEUROSCI.0378-21.2021
  44. Bauman, M. D., Iosif, A. M., Smith, S. E., Bregere, C., Amaral, D. G., & Patterson, P. H. (2014). Activation of the maternal immune system during pregnancy alters behavioral development of rhesus monkey offspring. Biological psychiatry, 75(4), 332–341. https://doi.org/10.1016/j.biopsych.2013.06.025
  45. Zhang, J., Yao, P., Han, W., Luo, Y., Li, Y., Yang, Y., Xia, H., Chen, Z., Chen, Q., Wang, H., Yang, L., Li, H., Hu, C., Huang, H., Peng, Z., Tan, X., Li, M., & Yang, J. (2022). Maternal Prenatal Inflammation Increases Brain Damage Susceptibility of Lipopolysaccharide in Adult Rat Offspring via COX-2/PGD-2/DPs Pathway Activation. International journal of molecular sciences, 23(11), 6142. https://doi.org/10.3390/ijms23116142
  46. Li, Y., Luo, W., Zhang, J., Luo, Y., Han, W., Wang, H., Xia, H., Chen, Z., Yang, Y., Chen, Q., Li, H., Yang, L., Hu, C., Huang, H., Peng, Z., Tan, X., Li, M., & Yang, J. (2022). Maternal Inflammation Exaggerates Offspring Susceptibility to Cerebral Ischemia-Reperfusion Injury via the COX-2/PGD2/DP2 Pathway Activation. Oxidative medicine and cellular longevity, 2022, 1571705. https://doi.org/10.1155/2022/1571705
  47. Careaga, M., Murai, T., & Bauman, M. D. (2017). Maternal Immune Activation and Autism Spectrum Disorder: From Rodents to Nonhuman and Human Primates. Biological psychiatry, 81(5), 391–401. https://doi.org/10.1016/j.biopsych.2016.10.020
  48. Weir, R. K., Forghany, R., Smith, S. E., Patterson, P. H., McAllister, A. K., Schumann, C. M., & Bauman, M. D. (2015). Preliminary evidence of neuropathology in nonhuman primates prenatally exposed to maternal immune activation. Brain, behavior, and immunity, 48, 139–146. https://doi.org/10.1016/j.bbi.2015.03.009
  49. Rose, D. R., Careaga, M., Van de Water, J., McAllister, K., Bauman, M. D., & Ashwood, P. (2017). Long-term altered immune responses following fetal priming in a non-human primate model of maternal immune activation. Brain, behavior, and immunity, 63, 60–70. https://doi.org/10.1016/j.bbi.2016.11.020
  50. Missault, S., Van den Eynde, K., Vanden Berghe, W., Fransen, E., Weeren, A., Timmermans, J. P., Kumar-Singh, S., & Dedeurwaerdere, S. (2014). The risk for behavioural deficits is determined by the maternal immune response to prenatal immune challenge in a neurodevelopmental model. Brain, behavior, and immunity, 42, 138–146. https://doi.org/10.1016/j.bbi.2014.06.013
  51. Vuillermot, S., Luan, W., Meyer, U., & Eyles, D. (2017). Vitamin D treatment during pregnancy prevents autism-related phenotypes in a mouse model of maternal immune activation. Molecular autism, 8, 9. https://doi.org/10.1186/s13229-017-0125-0
  52. Wang, X., Yang, J., Zhang, H., Yu, J., & Yao, Z. (2019). Oral probiotic administration during pregnancy prevents autism-related behaviors in offspring induced by maternal immune activation via anti-inflammation in mice. Autism research : official journal of the International Society for Autism Research, 12(4), 576–588. https://doi.org/10.1002/aur.2079
  53. Haddad, F. L., Patel, S. V., & Schmid, S. (2020). Maternal Immune Activation by Poly I:C as a preclinical Model for Neurodevelopmental Disorders: A focus on Autism and Schizophrenia. Neuroscience and biobehavioral reviews, 113, 546–567. https://doi.org/10.1016/j.neubiorev.2020.04.012Delorme, T. C., Srivastava, L. K., & Cermakian, N. (2021). Altered circadian rhythms in a mouse model of neurodevelopmental disorders based on prenatal maternal immune activation. Brain, behavior, and immunity, 93, 119–131. https://doi.org/10.1016/j.bbi.2020.12.030
  54. Mueller, F. S., Polesel, M., Richetto, J., Meyer, U., & Weber-Stadlbauer, U. (2018). Mouse models of maternal immune activation: Mind your caging system!. Brain, behavior, and immunity, 73, 643–660. https://doi.org/10.1016/j.bbi.2018.07.014
  55. Smolders, S., Notter, T., Smolders, S., Rigo, J. M., & Brône, B. (2018). Controversies and prospects about microglia in maternal immune activation models for neurodevelopmental disorders. Brain, behavior, and immunity, 73, 51–65. https://doi.org/10.1016/j.bbi.2018.06.001
  56. Fernández de Cossío, L., Guzmán, A., van der Veldt, S., & Luheshi, G. N. (2017). Prenatal infection leads to ASD-like behavior and altered synaptic pruning in the mouse offspring. Brain, behavior, and immunity, 63, 88–98. https://doi.org/10.1016/j.bbi.2016.09.028
  57. Tsukada, T., Shimada, H., Sakata-Haga, H., Iizuka, H., & Hatta, T. (2019). Molecular mechanisms underlying the models of neurodevelopmental disorders in maternal immune activation relevant to the placenta. Congenital anomalies, 59(3), 81–87. https://doi.org/10.1111/cga.12323
  58. Meyer U. (2019). Neurodevelopmental Resilience and Susceptibility to Maternal Immune Activation. Trends in neurosciences, 42(11), 793–806. https://doi.org/10.1016/j.tins.2019.08.001
  59. Massrali, A., Adhya, D., Srivastava, D. P., Baron-Cohen, S., & Kotter, M. R. (2022). Virus-Induced Maternal Immune Activation as an Environmental Factor in the Etiology of Autism and Schizophrenia. Frontiers in neuroscience, 16, 834058. https://doi.org/10.3389/fnins.2022.834058
  60. Wong, H., & Hoeffer, C. (2018). Maternal IL-17A in autism. Experimental neurology, 299(Pt A), 228–240. https://doi.org/10.1016/j.expneurol.2017.04.010
  61. Choi, G. B., Yim, Y. S., Wong, H., Kim, S., Kim, H., Kim, S. V., Hoeffer, C. A., Littman, D. R., & Huh, J. R. (2016). The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science (New York, N.Y.), 351(6276), 933–939. https://doi.org/10.1126/science.aad0314
  62. Li, Q., Li, J., Tian, J., Zhu, B., Zhang, Y., Yang, K., Ling, Y., & Hu, Y. (2012). IL-17 and IFN-γ production in peripheral blood following BCG vaccination and Mycobacterium tuberculosis infection in human. European review for medical and pharmacological sciences16(14), 2029–2036.
  63. Shen, H., Wang, Y., Chen, C. Y., Frencher, J., Huang, D., Yang, E., Ryan-Payseur, B., & Chen, Z. W. (2015). Th17-related cytokines contribute to recall-like expansion/effector function of HMBPP-specific Vγ2Vδ2 T cells after Mycobacterium tuberculosis infection or vaccination. European journal of immunology45(2), 442–451. https://doi.org/10.1002/eji.201444635
  64. Wozniak, T. M., Saunders, B. M., Ryan, A. A., & Britton, W. J. (2010). Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon. Infection and immunity78(10), 4187–4194. https://doi.org/10.1128/IAI.01392-09
  65. Burl, S., Adetifa, U. J., Cox, M., Touray, E., Ota, M. O., Marchant, A., Whittle, H., McShane, H., Rowland-Jones, S. L., & Flanagan, K. L. (2010). Delaying bacillus Calmette-Guérin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age. Journal of immunology (Baltimore, Md. : 1950)185(4), 2620–2628. https://doi.org/10.4049/jimmunol.1000552
  66. Freches, D., Romano, M., Korf, H., Renauld, J. C., Van Snick, J., Uyttenhove, C., & Huygen, K. (2011). Increased pulmonary tumor necrosis factor alpha, interleukin-6 (IL-6), and IL-17A responses compensate for decreased gamma interferon production in anti-IL-12 autovaccine-treated, Mycobacterium bovis BCG-vaccinated mice. Clinical and vaccine immunology : CVI18(1), 95–104. https://doi.org/10.1128/CVI.00352-10
  67. Pitt, J. M., Stavropoulos, E., Redford, P. S., Beebe, A. M., Bancroft, G. J., Young, D. B., & O’Garra, A. (2012). Blockade of IL-10 signaling during bacillus Calmette-Guérin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-γ and IL-17 responses and increases protection to Mycobacterium tuberculosis infection. Journal of immunology (Baltimore, Md. : 1950)189(8), 4079–4087. https://doi.org/10.4049/jimmunol.1201061
  68. Kim, S., Kim, H., Yim, Y. S., Ha, S., Atarashi, K., Tan, T. G., Longman, R. S., Honda, K., Littman, D. R., Choi, G. B., & Huh, J. R. (2017). Maternal gut bacteria promote neurodevelopmental abnormalities in mouse offspring. Nature, 549(7673), 528–532. https://doi.org/10.1038/nature23910
  69. Knuesel, I., Chicha, L., Britschgi, M., Schobel, S. A., Bodmer, M., Hellings, J. A., Toovey, S., & Prinssen, E. P. (2014). Maternal immune activation and abnormal brain development across CNS disorders. Nature reviews. Neurology, 10(11), 643–660. https://doi.org/10.1038/nrneurol.2014.187
  70. Bergdolt, L., & Dunaevsky, A. (2019). Brain changes in a maternal immune activation model of neurodevelopmental brain disorders. Progress in neurobiology, 175, 1–19. https://doi.org/10.1016/j.pneurobio.2018.12.002
  71. Bauman, M. D., & Van de Water, J. (2020). Translational opportunities in the prenatal immune environment: Promises and limitations of the maternal immune activation model. Neurobiology of disease, 141, 104864. https://doi.org/10.1016/j.nbd.2020.104864
  72. Ashe, P. C., Berry, M. D., & Boulton, A. A. (2001). Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents. Progress in neuro-psychopharmacology & biological psychiatry, 25(4), 691–707. https://doi.org/10.1016/s0278-5846(01)00159-2Rund B. R. (2009). Is schizophrenia a neurodegenerative disorder?. Nordic journal of psychiatry, 63(3), 196–201. https://doi.org/10.1080/08039480902767286
  73. Kochunov, P., & Hong, L. E. (2014). Neurodevelopmental and neurodegenerative models of schizophrenia: white matter at the center stage. Schizophrenia bulletin, 40(4), 721–728. https://doi.org/10.1093/schbul/sbu070
  74. Stone, W. S., Phillips, M. R., Yang, L. H., Kegeles, L. S., Susser, E. S., & Lieberman, J. A. (2022). Neurodegenerative model of schizophrenia: Growing evidence to support a revisit. Schizophrenia research, 243, 154–162. https://doi.org/10.1016/j.schres.2022.03.004
  75. Chien, Y. L., Lin, H. Y., Tung, Y. H., Hwang, T. J., Chen, C. L., Wu, C. S., Shang, C. Y., Hwu, H. G., Tseng, W. I., Liu, C. M., & Gau, S. S. (2022). Neurodevelopmental model of schizophrenia revisited: similarity in individual deviation and idiosyncrasy from the normative model of whole-brain white matter tracts and shared brain-cognition covariation with ADHD and ASD. Molecular psychiatry, 10.1038/s41380-022-01636-1. Advance online publication. https://doi.org/10.1038/s41380-022-01636-1de
  76. Mooij, S., Henson, R., Waldorp, L. J., & Kievit, R. A. (2018). Age Differentiation within Gray Matter, White Matter, and between Memory and White Matter in an Adult Life Span Cohort. The Journal of neuroscience : the official journal of the Society for Neuroscience, 38(25), 5826–5836. https://doi.org/10.1523/JNEUROSCI.1627-17.2018
  77. Cropley, V. L., Klauser, P., Lenroot, R. K., Bruggemann, J., Sundram, S., Bousman, C., Pereira, A., Di Biase, M. A., Weickert, T. W., Weickert, C. S., Pantelis, C., & Zalesky, A. (2017). Accelerated Gray and White Matter Deterioration With Age in Schizophrenia. The American journal of psychiatry, 174(3), 286–295. https://doi.org/10.1176/appi.ajp.2016.16050610
  78. Fletcher, E., Gavett, B., Harvey, D., Farias, S. T., Olichney, J., Beckett, L., DeCarli, C., & Mungas, D. (2018). Brain volume change and cognitive trajectories in aging. Neuropsychology, 32(4), 436–449. https://doi.org/10.1037/neu0000447
  79. Rao, J., Chiappelli, J., Kochunov, P., Regenold, W. T., Rapoport, S. I., & Hong, L. E. (2015). Is schizophrenia a neurodegenerative disease? Evidence from age-related decline of brain-derived neurotrophic factor in the brains of schizophrenia patients and matched nonpsychiatric controls. Neuro-degenerative diseases, 15(1), 38–44. https://doi.org/10.1159/000369214
  80. Rao, J., Chiappelli, J., Kochunov, P., Regenold, W. T., Rapoport, S. I., & Hong, L. E. (2015). Is schizophrenia a neurodegenerative disease? Evidence from age-related decline of brain-derived neurotrophic factor in the brains of schizophrenia patients and matched nonpsychiatric controls. Neuro-degenerative diseases, 15(1), 38–44. https://doi.org/10.1159/000369214
  81. Hollander, E., Wang, A. T., Braun, A., & Marsh, L. (2009). Neurological considerations: autism and Parkinson’s disease. Psychiatry research, 170(1), 43–51. https://doi.org/10.1016/j.psychres.2008.07.014
  82. Dinan, T. G., & Cryan, J. F. (2017). The Microbiome-Gut-Brain Axis in Health and Disease. Gastroenterology clinics of North America, 46(1), 77–89. https://doi.org/10.1016/j.gtc.2016.09.007
  83. Cryan, J. F., O’Riordan, K. J., Sandhu, K., Peterson, V., & Dinan, T. G. (2020). The gut microbiome in neurological disorders. The Lancet. Neurology, 19(2), 179–194. https://doi.org/10.1016/S1474-4422(19)30356-4
  84. Chen, Y., Xu, J., & Chen, Y. (2021). Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders. Nutrients, 13(6), 2099. https://doi.org/10.3390/nu13062099
  85. Fang, P., Kazmi, S. A., Jameson, K. G., & Hsiao, E. Y. (2020). The Microbiome as a Modifier of Neurodegenerative Disease Risk. Cell host & microbe, 28(2), 201–222. https://doi.org/10.1016/j.chom.2020.06.008Sasmita A. O. (2019). Modification of the gut microbiome to combat neurodegeneration. Reviews in the neurosciences, 30(8), 795–805. https://doi.org/10.1515/revneuro-2019-0005
  86. Fang X. (2016). Potential role of gut microbiota and tissue barriers in Parkinson’s disease and amyotrophic lateral sclerosis. The International journal of neuroscience, 126(9), 771–776. https://doi.org/10.3109/00207454.2015.1096271
  87. Peterson C. T. (2020). Dysfunction of the Microbiota-Gut-Brain Axis in Neurodegenerative Disease: The Promise of Therapeutic Modulation With Prebiotics, Medicinal Herbs, Probiotics, and Synbiotics. Journal of evidence-based integrative medicine, 25, 2515690X20957225. https://doi.org/10.1177/2515690X20957225
  88. Alfonsetti, M., Castelli, V., & d’Angelo, M. (2022). Are We What We Eat? Impact of Diet on the Gut-Brain Axis in Parkinson’s Disease. Nutrients, 14(2), 380. https://doi.org/10.3390/nu14020380
  89. Moustafa, S. A., Mohamed, S., Dawood, A., Azar, J., Elmorsy, E., Rizk, N., & Salama, M. (2021). Gut brain axis: an insight into microbiota role in Parkinson’s disease. Metabolic brain disease, 36(7), 1545–1557. https://doi.org/10.1007/s11011-021-00808-2
  90. Mulak, A., & Bonaz, B. (2015). Brain-gut-microbiota axis in Parkinson’s disease. World journal of gastroenterology, 21(37), 10609–10620. https://doi.org/10.3748/wjg.v21.i37.10609
  91. Gonatopoulos-Pournatzis, T., Niibori, R., Salter, E. W., Weatheritt, R. J., Tsang, B., Farhangmehr, S., Liang, X., Braunschweig, U., Roth, J., Zhang, S., Henderson, T., Sharma, E., Quesnel-Vallières, M., Permanyer, J., Maier, S., Georgiou, J., Irimia, M., Sonenberg, N., Forman-Kay, J. D., Gingras, A. C., … Blencowe, B. J. (2020). Autism-Misregulated eIF4G Microexons Control Synaptic Translation and Higher Order Cognitive Functions. Molecular cell, 77(6), 1176–1192.e16. https://doi.org/10.1016/j.molcel.2020.01.006
  92. Gonatopoulos-Pournatzis, T., Wu, M., Braunschweig, U., Roth, J., Han, H., Best, A. J., Raj, B., Aregger, M., O’Hanlon, D., Ellis, J. D., Calarco, J. A., Moffat, J., Gingras, A. C., & Blencowe, B. J. (2018). Genome-wide CRISPR-Cas9 Interrogation of Splicing Networks Reveals a Mechanism for Recognition of Autism-Misregulated Neuronal Microexons. Molecular cell, 72(3), 510–524.e12. https://doi.org/10.1016/j.molcel.2018.10.008
  93. Irimia, M., Weatheritt, R. J., Ellis, J. D., Parikshak, N. N., Gonatopoulos-Pournatzis, T., Babor, M., Quesnel-Vallières, M., Tapial, J., Raj, B., O’Hanlon, D., Barrios-Rodiles, M., Sternberg, M. J., Cordes, S. P., Roth, F. P., Wrana, J. L., Geschwind, D. H., & Blencowe, B. J. (2014). A highly conserved program of neuronal microexons is misregulated in autistic brains. Cell, 159(7), 1511–1523. https://doi.org/10.1016/j.cell.2014.11.035
  94. Quesnel-Vallières, M., Irimia, M., Cordes, S. P., & Blencowe, B. J. (2015). Essential roles for the splicing regulator nSR100/SRRM4 during nervous system development. Genes & development, 29(7), 746–759. https://doi.org/10.1101/gad.256115.114
  95. Raj, B., Irimia, M., Braunschweig, U., Sterne-Weiler, T., O’Hanlon, D., Lin, Z. Y., Chen, G. I., Easton, L. E., Ule, J., Gingras, A. C., Eyras, E., & Blencowe, B. J. (2014). A global regulatory mechanism for activating an exon network required for neurogenesis. Molecular cell, 56(1), 90–103. https://doi.org/10.1016/j.molcel.2014.08.011
  96. Raj, B., O’Hanlon, D., Vessey, J. P., Pan, Q., Ray, D., Buckley, N. J., Miller, F. D., & Blencowe, B. J. (2011). Cross-regulation between an alternative splicing activator and a transcription repressor controls neurogenesis. Molecular cell, 43(5), 843–850. https://doi.org/10.1016/j.molcel.2011.08.014
  97. Saso, A., & Kampmann, B. (2017). Vaccine responses in newborns. Seminars in immunopathology39(6), 627–642. https://doi.org/10.1007/s00281-017-0654-9
  98. Chaudhari T. (2021). Vaccinations in the newborn. Best practice & research. Clinical obstetrics & gynaecology76, 66–82. https://doi.org/10.1016/j.bpobgyn.2020.09.004
  99. Sakala, I. G., Eichinger, K. M., & Petrovsky, N. (2019). Neonatal vaccine effectiveness and the role of adjuvants. Expert review of clinical immunology15(8), 869–878. https://doi.org/10.1080/1744666X.2019.1642748
  100. Clemens, E. A., & Alexander-Miller, M. A. (2021). Understanding Antibody Responses in Early Life: Baby Steps towards Developing an Effective Influenza Vaccine. Viruses13(7), 1392. https://doi.org/10.3390/v13071392
  101. Nguyen, M., Julien, JP. & Rivest, S. Innate immunity: the missing link in neuroprotection and neurodegeneration?. Nat Rev Neurosci 3, 216–227 (2002). https://doi.org/10.1038/nrn752
  102. Lehnardt S. (2010). Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia58(3), 253–263. https://doi.org/10.1002/glia.20928
  103. Woods, J. A., Vieira, V. J., & Keylock, K. T. (2006). Exercise, inflammation, and innate immunity. Neurologic clinics24(3), 585–599. https://doi.org/10.1016/j.ncl.2006.03.008
  104. Scheffer, D., & Latini, A. (2020). Exercise-induced immune system response: Anti-inflammatory status on peripheral and central organs. Biochimica et biophysica acta. Molecular basis of disease1866(10), 165823. https://doi.org/10.1016/j.bbadis.2020.165823
  105. Petersen, A. M., & Pedersen, B. K. (2006). The role of IL-6 in mediating the anti-inflammatory effects of exercise. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society57 Suppl 10, 43–51.
  106. Zengeler, K. E., & Lukens, J. R. (2021). Innate immunity at the crossroads of healthy brain maturation and neurodevelopmental disorders. Nature reviews. Immunology21(7), 454–468. https://doi.org/10.1038/s41577-020-00487-7
  107. Filiano, A. J., Gadani, S. P., & Kipnis, J. (2015). Interactions of innate and adaptive immunity in brain development and function. Brain research1617, 18–27. https://doi.org/10.1016/j.brainres.2014.07.050
  108. Filipello, F., Morini, R., Corradini, I., Zerbi, V., Canzi, A., Michalski, B., Erreni, M., Markicevic, M., Starvaggi-Cucuzza, C., Otero, K., Piccio, L., Cignarella, F., Perrucci, F., Tamborini, M., Genua, M., Rajendran, L., Menna, E., Vetrano, S., Fahnestock, M., Paolicelli, R. C., … Matteoli, M. (2018). The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity. Immunity48(5), 979–991.e8. https://doi.org/10.1016/j.immuni.2018.04.016
  109. Al-Haddad, B., Oler, E., Armistead, B., Elsayed, N. A., Weinberger, D. R., Bernier, R., Burd, I., Kapur, R., Jacobsson, B., Wang, C., Mysorekar, I., Rajagopal, L., & Adams Waldorf, K. M. (2019). The fetal origins of mental illness. American journal of obstetrics and gynecology221(6), 549–562.
  110. Pape, K., Tamouza, R., Leboyer, M., & Zipp, F. (2019). Immunoneuropsychiatry – novel perspectives on brain disorders. Nature reviews. Neurology15(6), 317–328. https://doi.org/10.1038/s41582-019-0174-4
  111. Ornoy, A., Weinstein-Fudim, L., & Ergaz, Z. (2015). Prenatal factors associated with autism spectrum disorder (ASD). Reproductive toxicology (Elmsford, N.Y.)56, 155–169. https://doi.org/10.1016/j.reprotox.2015.05.007
  112. Gasser, B. A., Buerki, S. F., Kurz, J., & Mohaupt, M. G. (2021). Hyperandrogenism? Increased 17, 20-Lyase Activity? A Metanalysis and Systematic Review of Altered Androgens in Boys and Girls with Autism. International journal of molecular sciences22(22), 12324. https://doi.org/10.3390/ijms222212324
  113. Figueiredo, C. P., Fontes-Dantas, F. L., da Poian, A. T., & Clarke, J. R. (2021). SARS-CoV-2-associated cytokine storm during pregnancy as a possible risk factor for neuropsychiatric disorder development in post-pandemic infants. Neuropharmacology201, 108841. https://doi.org/10.1016/j.neuropharm.2021.108841 https://doi.org/10.1016/j.ajog.2019.06.013
  114. Xu, Z. X., Kim, G. H., Tan, J. W., Riso, A. E., Sun, Y., Xu, E. Y., Liao, G. Y., Xu, H., Lee, S. H., Do, N. Y., Lee, C. H., Clipperton-Allen, A. E., Kwon, S., Page, D. T., Lee, K. J., & Xu, B. (2020). Elevated protein synthesis in microglia causes autism-like synaptic and behavioral aberrations. Nature communications11(1), 1797. https://doi.org/10.1038/s41467-020-15530-3
  115. Salter, M. W., & Stevens, B. (2017). Microglia emerge as central players in brain disease. Nature medicine23(9), 1018–1027. https://doi.org/10.1038/nm.4397
  116. Eberl, G. A new age for (mucosal) NeuroImmunology. Mucosal Immunol (2022). https://doi.org/10.1038/s41385-022-00573-0
  117. Lutein, Brain, and Neurological Functions. (2015). Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease, 41–47. https://doi.org/10.1016/b978-0-12-411462-3.00004-7
  118. Guglielmi, L., Servettini, I., Caramia, M., Catacuzzeno, L., Franciolini, F., D’Adamo, M. C., & Pessia, M. (2015). Update on the implication of potassium channels in autism: K(+) channelautism spectrum disorder. Frontiers in cellular neuroscience9, 34. https://doi.org/10.3389/fncel.2015.00034
  119. Reid, K. H., Guo, S. Z., & Iyer, V. G. (2000). Agents which block potassium-chloride cotransport prevent sound-triggered seizures in post-ischemic audiogenic seizure-prone rats. Brain research864(1), 134–137. https://doi.org/10.1016/s0006-8993(00)02121-1
  120. Martel, P., Leo, D., Fulton, S., Bérard, M., & Trudeau, L. E. (2011). Role of Kv1 potassium channels in regulating dopamine release and presynaptic D2 receptor function. PloS one6(5), e20402. https://doi.org/10.1371/journal.pone.0020402
  121. Fung, L. K., Libove, R. A., Phillips, J., Haddad, F., & Hardan, A. Y. (2014). Brief report: an open-label study of the neurosteroid pregnenolone in adults with autism spectrum disorder. Journal of autism and developmental disorders44(11), 2971–2977. https://doi.org/10.1007/s10803-014-2144-4
  122. Geier, D. A., & Geier, M. R. (2006). A clinical trial of combined anti-androgen and anti-heavy metal therapy in autistic disorders. Neuro endocrinology letters27(6), 833–838.
  123. Palomba, S., Orio, F., Jr, Falbo, A., Oppedisano, R., Tolino, A., & Zullo, F. (2008). Tibolone reverses the cognitive effects caused by leuprolide acetate administration, improving mood and quality of life in patients with symptomatic uterine leiomyomas. Fertility and sterility90(1), 165–173. https://doi.org/10.1016/j.fertnstert.2007.05.061
  124. Medical article indicating a possible efficacy of leuprolide acetate against Alzheimer’s Disease; available at: https://www.neurologyadvisor.com/topics/alzheimers-disease-and-dementia/leuprolide-acetate-potential-treatment-for-alzheimer-disease-in-women/
  125. Schober, J. M., Kuhn, P. J., Kovacs, P. G., Earle, J. H., Byrne, P. M., & Fries, R. A. (2005). Leuprolide acetate suppresses pedophilic urges and arousability. Archives of sexual behavior34(6), 691–705. https://doi.org/10.1007/s10508-005-7929-2
  126. Briken, P., Berner, W., Noldus, J., Nika, E., & Michl, U. (2000). Therapie mit dem LHRH-Agonisten Leuprorelinacetat bei Paraphilien und sexuell aggressiven Impulshandlungen [Treatment of paraphilia and sexually aggressive impulsive behavior with the LHRH-agonist leuprolide acetate]. Der Nervenarzt71(5), 380–385. https://doi.org/10.1007/s001150050572
  127. Hu, Z. Y., Bourreau, E., Jung-Testas, I., Robel, P., & Baulieu, E. E. (1987). Neurosteroids: oligodendrocyte mitochondria convert cholesterol to pregnenolone. Proceedings of the National Academy of Sciences of the United States of America84(23), 8215–8219. https://doi.org/10.1073/pnas.84.23.8215
  128. Jung-Testas, I., Hu, Z. Y., Baulieu, E. E., & Robel, P. (1989). Neurosteroids: biosynthesis of pregnenolone and progesterone in primary cultures of rat glial cells. Endocrinology125(4), 2083–2091. https://doi.org/10.1210/endo-125-4-2083
  129. Máčová, L., Bičíková, M., Ostatníková, D., Hill, M., & Stárka, L. (2017). Vitamin D, neurosteroids and autism. Physiological research66(Suppl 3), S333–S340. https://doi.org/10.33549/physiolres.933721
  130. Maguire J. (2016). Neurosteroid Deficiency Associated With Epilepsy. Epilepsy currents16(2), 108–109. https://doi.org/10.5698/1535-7511-16.2.108
  131. Siracusano, M., Riccioni, A., Abate, R., Benvenuto, A., Curatolo, P., & Mazzone, L. (2020). Vitamin D Deficiency and Autism Spectrum Disorder. Current pharmaceutical design26(21), 2460–2474. https://pubmed.ncbi.nlm.nih.gov/32294031/
  132. Reddy D. S. (2022). Neurosteroid replacement therapy for catamenial epilepsy, postpartum depression and neuroendocrine disorders in women. Journal of neuroendocrinology34(2), e13028. https://pubmed.ncbi.nlm.nih.gov/34506047/
  133. The Urban Child Institute (2011), Memphis’ Education Funding Misses Best Chance For Impact, https://urbanchildinstitute.org/articles/perceptions/memphis-education-funding-misses-best-chance-for-impact
  134. Transcranial Magnetic Stimulation: https://neuromodec.org/what-is-transcranial-magnetic-stimulation-tms/

By Anonymous Graduate

A graduate from a Science-related University Bachelor's, discussing public health corruption and half-truths promoted abundantly in mainstream Academia.

Leave a Reply

Your email address will not be published. Required fields are marked *